These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21673580)

  • 1. Technical standards and guidelines for spinal muscular atrophy testing.
    Prior TW; Nagan N; Sugarman EA; Batish SD; Braastad C
    Genet Med; 2011 Jul; 13(7):686-94. PubMed ID: 21673580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal Muscular Atrophy: Overview of Molecular Diagnostic Approaches.
    Prior TW; Nagan N
    Curr Protoc Hum Genet; 2016 Jan; 88():9.27.1-9.27.13. PubMed ID: 26724723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal muscular atrophy: newborn and carrier screening.
    Prior TW
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
    Wirth B
    Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.
    Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B
    Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal muscular atrophy diagnostics.
    Prior TW
    J Child Neurol; 2007 Aug; 22(8):952-6. PubMed ID: 17761649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal muscular atrophy: molecular genetics and diagnostics.
    Ogino S; Wilson RB
    Expert Rev Mol Diagn; 2004 Jan; 4(1):15-29. PubMed ID: 14711346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gene copy ratios of SMN1/SMN2 in Japanese carriers with type I spinal muscular atrophy.
    Diep Tran T; Kroepfl T; Saito M; Nagura M; Ichiseki H; Kubota M; Toda T; Sakakihara Y
    Brain Dev; 2001 Aug; 23(5):321-6. PubMed ID: 11504604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic testing and risk assessment for spinal muscular atrophy (SMA).
    Ogino S; Wilson RB
    Hum Genet; 2002 Dec; 111(6):477-500. PubMed ID: 12436240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantification of SMN1 and SMN2 copy numbers by MALDI-TOF mass spectrometry for spinal muscular atrophy genetic testing.
    Jin W; Yang Z; Tang X; Wang X; Huang Y; Hui C; Yao J; Luan J; Tang S; Wu S; Jin S; Ding C
    Clin Chim Acta; 2022 Jul; 532():45-52. PubMed ID: 35643151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Reference Materials for Spinal Muscular Atrophy Genetic Testing: A Genetic Testing Reference Materials Coordination Program Collaborative Project.
    Prior TW; Bayrak-Toydemir P; Lynnes TC; Mao R; Metcalf JD; Muralidharan K; Iwata-Otsubo A; Pham HT; Pratt VM; Qureshi S; Requesens D; Shen J; Vetrini F; Kalman L
    J Mol Diagn; 2021 Jan; 23(1):103-110. PubMed ID: 33197628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a molecular diagnostic system for spinal muscular atrophy experience from a clinical laboratory in china.
    Zeng J; Lin Y; Yan A; Ke L; Zhu Z; Lan F
    J Mol Diagn; 2011 Jan; 13(1):41-7. PubMed ID: 21227393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of intragenic SMN1 mutations in spinal muscular atrophy patients with a single copy of SMN1.
    Ganji H; Nouri N; Salehi M; Aryani O; Houshmand M; Basiri K; Fazel-Najafabadi E; Sedghi M
    J Child Neurol; 2015 Apr; 30(5):558-62. PubMed ID: 24563475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
    Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
    Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients.
    Yamamoto T; Sato H; Lai PS; Nurputra DK; Harahap NI; Morikawa S; Nishimura N; Kurashige T; Ohshita T; Nakajima H; Yamada H; Nishida Y; Toda S; Takanashi J; Takeuchi A; Tohyama Y; Kubo Y; Saito K; Takeshima Y; Matsuo M; Nishio H
    Brain Dev; 2014 Nov; 36(10):914-20. PubMed ID: 24359787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives and diagnostic considerations in spinal muscular atrophy.
    Prior TW
    Genet Med; 2010 Mar; 12(3):145-52. PubMed ID: 20057317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.
    Tan CA; Westbrook MJ; Truty R; Kvitek DJ; Kennemer M; Winder TL; Shieh PB
    Genet Test Mol Biomarkers; 2020 Oct; 24(10):616-624. PubMed ID: 32721234
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test.
    Su YN; Hung CC; Li H; Lee CN; Cheng WF; Tsao PN; Chang MC; Yu CL; Hsieh WS; Lin WL; Hsu SM
    Hum Mutat; 2005 May; 25(5):460-7. PubMed ID: 15832310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal Muscular Atrophy.
    Kolb SJ; Kissel JT
    Neurol Clin; 2015 Nov; 33(4):831-46. PubMed ID: 26515624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.